Latest news articles

Added 2 months ago Drug news

CE Mark for Myval transcatheter aortic heart valve

Meril Life Sciences, a company based in India, has obtained the European CE mark of approval for its Myval transcatheter...

Added 3 months ago Drug news

The COMMENCE study shows that bioprosthetic surgical aortic valves with RESILIA tissue platform continue to demonstrate favorable safety and hemodynamic performance through four years follow-up. Edwards Lifesciences.

Edwards Lifesciences Corporation announced results from the COMMENCE clinical study. The data show that Edwards' bioprosthetic surgical aortic valves featuring...

Added 3 months ago Drug news

FDA approves LOTUS Edge Aortic Valve System to treat severe aortic stenosis

Boston Scientific Corporation announced it has received FDA approval for the LOTUS Edge Aortic Valve System. Delivered via a minimally-invasive...

Search all news articles for Heart valve disorders
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Load more

Guidelines

2018 ESC/EACTS Guidelines on myocardial revascularization

These Guidelines represent the third time that the ESC and EACTS have brought together cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body of evidence, with the mission of drafting balanced...

Added 4 years ago

2017 ESC/EACTS Guidelines for the management of valvular heart disease

These guidelines focus on acquired VHD, are oriented towards management and do not deal with endocarditis or congenital valve disease, including pulmonary valve disease, as separate guidelines have been published by the ESC on these topics.

Added 7 years ago

Search all guidelines for Heart valve disorders
 

Journal articles

Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.

Background: Valvular heart disease (VHD) and atrial fibrillation (AF) often coexist. Phase III trials comparing non–vitamin K antagonist oral anticoagulants (NOACs) with warfarin excluded patients with moderate/severe mitral...

Added 8 days ago

Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.

Background: The original non–vitamin K antagonist oral anticoagulant (NOAC) trials in nonvalvular atrial fibrillation (AF) enrolled patients with native valve pathologies. The object of this study was to quantify the...

Added 9 days ago

Safety and Feasibility of Treatment with Rivaroxaban for Non-Canonical Indications: A Case Series Analysis.

The new oral anticoagulants (NOACs) are used for the prevention of thromboembolic complications in patients with non-valvular atrial fibrillation (AF) and those at risk of deep venous thrombosis.

Added 2 years ago

Search all journal articles for Heart valve disorders
 

CME

Innocent cardiac murmurs in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0
Search all CME for Heart valve disorders